Author

Jeremy Rich

Centre National de la Recherche ScientifiqueORCID 0009-0006-3957-3000Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Jeremy Rich1 paper · University of North Carolina at Chapel Hill

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Antonin MarchaisiD· 1 shared Birgit GeoergeriD· 1 shared Fayez IssaiD· 1 shared Guillaume MeuriceiD· 1 shared Hana RaslováiD· 1 shared Iryna PirozhkovaiD· 1 shared Julien Alberola· 1 shared Kamel MamchaouiiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Antonin MarchaisORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Molecular BiologyEMBO Molecular MedicinePeer-reviewedJul 15, 2024

DiPRO1 dependent transcriptional and epigenetic regulation distinctly controls the fate of muscle and mesenchymal cancer cells.

Jeremy Rich, Melanie Bennaroch, Laura Notel…·Iryna Pirozhkova

This paper identifies DiPRO1 as a regulator of myoblast differentiation and mesenchymal tumor suppression through epigenetic and transcriptional mechanisms, showing its potential as a therapeutic target.

2 citations

humanDNA methylation

𝕏 PostBluesky